Crossmark

Immunomodulatory Phenylboronic Acid-Chitosan Hydrogel Integrated with β-CD/Curcumin for Targeted Conjunctivitis Therapy

Published Online: 2026-06-15

Authors

Deng, Zifeng

Wang, Xilang
License Information

Text and Data Mining valid from 2026-06-15

Version of Record valid from 2026-06-15
More Information

Article History

Received: 20 April 2026

Accepted: 9 June 2026

First Online: 15 June 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current